Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately ...

Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...

They studied 36 FFPE samples from patients with meningioma – a common and benign brain tumor – and used a novel computational approach to integrate this data with nearly 1,300 publicly ...

The patient - Adan (name changed) - presented with symptoms of left-sided weakness persisting for a year and headaches ...

The Rotorua woman is going to the US this month for surgery and radiation, costing about $550,000. It was a “hard decision” ...